Condition: Ischemic Stroke · Remote Ischaemic Preconditioning · Sponsor: Jinling Hospital, China
This study aims to conduct a prospective, randomized, double-blind, multicenter, parallel-controlled, group-sequential trialto scientifically evaluate the safety and efficacy of remote ischemic preconditioning (RIC) in preventing early neurological deterioration (END) in patients with acute perforating artery infarction (PAI).
This description comes directly from the study's public registry record.
Wusheng Zhu, PhD · +86 2584801861 · wusheng.zhu@nju.edu.cn
Always discuss trial participation with your own doctor first.
| Jinling Hospital, Medical School of Nanjing University, Nanjing | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07237542